Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Award
- up to £8.6m
- Closes
- 17 February 2027
- Funder
- European Commission (Horizon Europe)
Who can apply for Clinical trials for advancing innovative interventions for neurodegenerative diseases?
Clinical trials for advancing innovative interventions for neurodegenerative diseases is a funding programme from European Commission (Horizon Europe), offering up to £8.6m and closing on 17 February 2027. Below are the eligibility rules EchoGrant read from the funder's own page, grouped by what they cover. They are quoted from the funder, so treat the official page as the final word.
Who can apply
- The participation of tart-up , micro, mall and medium- ized enterpri e (SME ) i encouraged with the aim of trengthening their cientific and technological foundation , enhancing their innovation potential, and exploring po ibilitie for commercial exploitation.
Where you need to be based
- Location: UK. The UK i a ociated to Horizon Europe, o UK organi ation can apply on the ame term a EU one unle the condition below ay otherwi e.
Sector or focus
- Neurodegenerative di ea e are a high burden for patient , caregiver , health y tem and ociety. Given the limitation with current therapeutic olution ... there i a huge need to develop more innovative, afer and more effective therapeutic olution for the e di ea e .
What the funding is for
- Perform rigorou early- tage clinical trial into the afety and efficacy of the innovative intervention and their mode of admini tration
Who cannot apply
- Rare neurodegenerative di ea e are excluded. Rare di ea e , a defined by the European Union Regulation on Orphan Medicinal Product (1999), being a di ea e that affect not more than 1 per on per 2000 in the European population.
Do you meet these rules?
EchoGrant checks your organisation against every rule above and tells you which ones you pass, which you fail and which need an answer from you.
Common questions
Who can apply for Clinical trials for advancing innovative interventions for neurodegenerative diseases?
The participation of tart-up , micro, mall and medium- ized enterpri e (SME ) i encouraged with the aim of trengthening their cientific and technological foundation , enhancing their innovation potential, and exploring po ibilitie for commercial exploitation. This is the funder’s own wording; check the official page before you apply.
How much is the Clinical trials for advancing innovative interventions for neurodegenerative diseases award?
The funder’s page gives the award as up to £8.6m. Check the official page for how it is paid and any match funding.
When is the Clinical trials for advancing innovative interventions for neurodegenerative diseases deadline?
The deadline we have recorded is 17 February 2027. Funders sometimes move dates, so confirm on the official page.
Information is taken from the funder's public page and may be out of date. EchoGrant is not the funder and does not guarantee eligibility or funding. Always confirm details with the funder before applying.